Periksa Hepatitis

estimate the predictive risk score in patients with chronic hepatitis

This application will help you or medical personnel such as sisters, doctors, nurses or other health workers. To help the function of diagnosing hepatitis that is suffered by the patient.

This application will estimate the prediction risk score in patients with chronic hepatitis B. With the complex calculation method of genitals, age, serum Alt concentration, HBeag status, and HBC serum level DNA level.

Risk-SCORE Table 17 There are points developed and validated with clinical factors. Risk scores produced are accurate and reliable, with the risk estimated to be good with the risks observed.

These risk-predicted instruments can be used by various health professionals, from general practitioners for experienced hepatologists. It may also provide valuable insights for health authorities require information for long -term resource planning. And it is hoped that this can provide a calculation of treatment to Pasient and for those who require therapy well and quality. Hope it is useful

Compared to the HIV virus, the hepatitis B (HBV) virus is one hundred times more fierce, and ten times more transmitting. Most symptoms of hepatitis B are not real.

Chronic hepatitis B is a chronic liver necroinflammatory disease caused by a persistent hepatitis B virus infection.

Chronic hepatitis B is characterized by positive HBsag (> 6 months) in the serum, high levels of HBV DNA and the ongoing process of chronic liver necroflamation. Inactive HBSAG Carrier is defined as a persistent HBV infection without necroinflammation. While the chronic hepatitis B exacerbation is a clinical state characterized by an increase in intermittent alt> 10 times the upper limit of the normal value (bann). The diagnosis of chronic hepatitis B infections is based on serological examination, virological markers, biochemistry and histology.

In serological, the recommended examination for the diagnosis and evaluation of chronic hepatitis B infections is: HBsAg, HBEAG, Anti HBE and HBV DNA (4.5). Virology examination, carried out to measure the number of HBV DNA serum is very important because it can describe the level of virus replication. Biochemical examination that is important for determining therapeutic decisions is ALT levels. Increasing ALT levels illustrates the presence of croflamation activity.

Therefore this examination is considered as a prediction of histological features. Patients with Alt levels showing the process of necroinflammation are heavier than in normal ALT. Patients with normal ALT levels have an unfavorable serological response in antiviral therapy. Therefore patients with normal ALT levels are considered not treated, except when the results of histology examination indicate the process of active necroinflammation. While the purpose of histological examination is to assess the level of liver damage, set aside the diagnosis of other liver diseases, prognosis and determine anti -viral management.

In general, symptoms of mild hepatitis B disease. These symptoms can be in the form of disappearing appetite, discomfort in the stomach, nausea to vomiting, mild fever, sometimes accompanied by joint pain and swelling in the upper right abdomen. After one week the main symptoms will occur such as the white parts of the eyes look yellow, the whole body looks yellow and urine colored like tea.

There are 3 possible immunity responses given by the body to the Hepatitis B virus after the acute period. The first possibility, if an adequate immune response will occur a virus cleaning, the patient is cured. Second, if the immune response is weak, the patient will become an inactive carrier. Third, if the body's response is intermediate (between the two things above) then the disease continues to develop into chronic hepatitis B.

What's New In The Latest Version 3.6